Deep-vein thromboses aka blood clots seemingly appear out of nowhere. Chemo can cause blood clots. Cancer can cause blood clots. Sitting can cause blood clots. Make no mistake. Blood clots are complicated, sneaky and can kill. As one of the blog posts linked and excerpted below explains, conventional therapies such as blood thinning drugs don’t always prevent blood clots. And blood thinning therapies come with side effects of their own.
So what is a person to do? While I’m not a board certified medical doctor and therefore can’t prescribe medicine, I can tell you what I do, how I have remained free from deep vein thromboses since I developed my own chemotherapy-induced DVT in 1995.
Let me be clear. Conventional therapies such as coumadin, Xarelto, Pradaxa, Eliquis, etc. are the norm. I am saying that coumadin caused side effects from me and short, long-term and late stage side effects need to be clearly understood.
Benefit of chemotherapy?
Was the benefit of my chemo worth my blood clots? Does chemotherapy help cancer patients? Is the cure worse than the disease? I’m not going to tackle that debate in this blog post certainly. But I will say that each and every chemotherapy I underwent from my original diagnosis through my oncologist telling me “we can do nothing more for you” should have been treated with one or more prophylactic therapies to reduce my risk of a blood clot.
Alternatives to chemotherapy?
Again, this is too big, too complicated a question to be debated in this blog post. In the case of this post, DVTs, blood clots, the issue is prevention and prophylactics.
Therapies to heal or prevent chemotherapy-induced deep vein thrombosis?
If you have ever had a deep-vein thrombosis/DVT/bloot clot, your live with an increased risk of having another blood clot. Scroll down the page, post a question or a comment and I will reply to you ASAP.
“…over 9,000 multiple myeloma patients, we found, in contrast to previously published studies, that the occurrence of any thrombosis was associated with a significantly poorer survival.”
Hyper-viscosity causes deep vein thrombosis aka blood clots. Blood clots can be caused by multiple myeloma and by chemotherapy to treat MM. Blood clots (thrombotic event) is one of the top five causes of death for MM survivors.
I developed my first blood clot shortly after I began my first course of induction therapy (1995) and I developed my second clot in the other leg a few years later…”
“Overall, a substantial risk of VTE associated with lenalidomide-based regimens (MM side effect) was evident in controlled clinical trial settings, despite adequate thromboprophylaxis…”
“The 4 cardiovascular and thromboembolic diseases resulting in death in patients with MM were atherosclerosis (n = 88), heart disease (n = 3799), aortic aneurysm and dissection (n = 39), and cerebrovascular disease (n = 1861)…”
“Mom takes one of the standard-of-care, FDA approved blood thinners linked and excerpted below. I do not take a conventional blood thinner. I learned about the laundry list of potential side effects that come with conventional blood thinners and I decided to lower my risk of stroke by supplementing…”
“More than one-third of patients with DVT will develop PTS, and 5% to 10% of patients will develop severe PTS, which may manifest as venous ulceration…”
“low serum vitamin D levels were independent predictors of DVT in patients with ischemic stroke during inpatient rehabilitation stay in China.
Because I have an increased risk of stroke (Afib) I normally blog about the risk of a first stroke. The study linked below talks about the stroke patient’s risk of a DVT aka blood clot after they have suffered an ischemic stroke…”
“Patients with an acute medical illness such as pneumonia, stroke, or congestive heart failure are highly susceptible to the development of venous thromboembolism (VTE) during their hospital stay and up to 3-months postdischarge.1,2″
“By age 45, 56% of the childhood cancer survivors diagnosed before age 15 had developed severe health problems, compared with 39% of survivors diagnosed in adolescence or early adulthood and 12% of the siblings…”
“With an aging population and a rising prevalence of obesity and cancer (MM), the incidence of VTE is expected to increase in the coming years…”
“However, studies exist proving it will slow or inhibit formation of clots. This attribute, although useful in many cases, may also be associated with serious risks, so know the benefits versus the risks of consumption and how they apply to your health…